Carcinoid syndrome epidemiology and demographics: Difference between revisions
Jump to navigation
Jump to search
(→Gender) |
|||
| Line 3: | Line 3: | ||
{{CMG}}{{AE}}{{PSD}} | {{CMG}}{{AE}}{{PSD}} | ||
==Overview== | ==Overview== | ||
The prevalence of carcinoid syndrome is approximately 1.5 per 100,000 individuals worldwide. The incidence of carcinoid syndrome is approximately | The prevalence of carcinoid syndrome is approximately 1.5 per 100,000 individuals worldwide. The incidence of carcinoid syndrome is approximately 2 per 100,000 individuals worldwide. The median age at diagnosis is 61.4 years. | ||
==Epidemiology and Demographics== | ==Epidemiology and Demographics== | ||
Revision as of 17:19, 29 September 2015
|
Carcinoid syndrome Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Carcinoid syndrome epidemiology and demographics On the Web |
|
American Roentgen Ray Society Images of Carcinoid syndrome epidemiology and demographics |
|
Carcinoid syndrome epidemiology and demographics in the news |
|
Risk calculators and risk factors for Carcinoid syndrome epidemiology and demographics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Parminder Dhingra, M.D. [2]
Overview
The prevalence of carcinoid syndrome is approximately 1.5 per 100,000 individuals worldwide. The incidence of carcinoid syndrome is approximately 2 per 100,000 individuals worldwide. The median age at diagnosis is 61.4 years.
Epidemiology and Demographics
Incidence
- The incidence of carcinoid syndrome is estimated to be 2 cases per 100,000 individuals worldwide.[1]
- The median age at diagnosis is 60.9 years.[2]
- Carcinoid tumors represent about 0.5% of all newly diagnosed malignancies.
- Carcinoid tumors account for 75% of all gastrointestinal endocrine tumors.
- Ovarian carcinoid tumors account for 0.3% of all ovarian tumors and 0.5% of carcinoid tumors.[3]
Age
- Ovarian carcinoid tumors are commonly seen in perimenopausal and postmenopausal women.
Gender
- Females are more commonly affected with carcinoid syndrome than males.
- Males are more commonly affected with thymic carcinoid tumor than females. The male to female ratio is approximately 3 to 1.[4]
References
- ↑ Epidemiology of carcinoid tumor. National cancer institute. http://www.cancer.gov/types/gi-carcinoid-tumors/hp/gi-carcinoid-treatment-pdq
- ↑ Maggard MA, O'Connell JB, Ko CY (2004). "Updated population-based review of carcinoid tumors". Ann Surg. 240 (1): 117–22. PMC 1356383. PMID 15213627.
- ↑ Ovarian carcinoid tumors.Radiopaedia (date). http://radiopaedia.org/articles/ovarian-carcinoid-tumours
- ↑ Thymic carcinoid tumour. Radiopaedia. http://radiopaedia.org/articles/thymic-carcinoid-tumour Accessed on September 24, 2015